Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...

IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Abhi Moolupuri discussing a PET/CT supplemented approach to omission of pelvic lymph node dissection. The National ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

Many cancer patients seeking treatment abroad are surprised to find that the same medications and therapies are available in ...

The Government of Alberta has made Pluvicto, a new radiopharmaceutical treatment for advanced prostate cancer, available to Albertans in an effort to improve treatment access.

(UroToday.com) Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics 2025 held in Lugano, Switzerland was host to a session addressing the contemporary management of metastatic prostate ...

Srinagar- The government on Friday said that Jammu and Kashmir reports 2 to 3 percent increase in cancer cases every year.

Award-winning research presented at ESR 2025 reveals energy-efficient diagnostic approaches for metastatic breast cancer, ...

Pluvicto is a new radiopharmaceutical treatment for advanced prostate cancer.